May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Quantum Dot Mediated Mouse Vascular Endothelial Cell Killing
Author Affiliations & Notes
  • K.L. Masselam
    New York University School of Medicine, New York, NY
    Ophthalmology,
  • J.A. Young
    New York University School of Medicine, New York, NY
    Ophthalmology,
  • J. Karen
    New York University School of Medicine, New York, NY
    Dermatology,
  • P.–J. Yu
    New York University School of Medicine, New York, NY
    Cardiovascular Surgery,
  • P. Mignatti
    New York University School of Medicine, New York, NY
    Cardiovascular Surgery,
  • Footnotes
    Commercial Relationships  K.L. Masselam, None; J.A. Young, None; J. Karen, None; P. Yu, None; P. Mignatti, None.
  • Footnotes
    Support  Macula Foundation
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5346. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K.L. Masselam, J.A. Young, J. Karen, P.–J. Yu, P. Mignatti; Quantum Dot Mediated Mouse Vascular Endothelial Cell Killing . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5346.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To employ surface plasmon resonance to target and kill endothelial cells by means of IgG–conjugated quantum dots (gold nanospheres).

Methods: : 6 confluent monolayers of mouse vascular endothelial cells grown in 2% gelatin–coated 4–well LabTek glass chambered slides were each incubated with 1 µg/ml anti–mouse CD31 (PECAM–1) monoclonal rat IgG for 30 minutes at 37º. Three 500 µl 1% BSA washes were performed in all wells. Monolayers in wells #1, 3, 5 were incubated with 30nm quantum dots (gold nanospheres) conjugated with 1 µg/ml anti–rat IgG goat IgG at 37º for 30 minutes. One 500 µl 1% BSA wash was performed in all six wells. Endothelial monolayers were covered with 500 µl of media per well and wells #1–2 and 3–4 were irradiated with 50 or 100 pulses, respectively, of a 532–nm, 0.5 J/cm2, Q–switched Nd:YAG laser (6 mm spot). Media was removed and Trypan blue exclusion testing was performed to assay cell viability. Viable and non–viable cells were counted within the 6 mm irradiated spot for wells #1–4 and within a corresponding area for wells #5–6 by using an Axiovert 25 microscope (Carl Zeiss, Inc., Thornwood, NY) with a CWHK grid ocular (Olympus America Inc., Melville, NY) (ob 10×).

Results: : Unirradiated cells (wells # 5 and 6) demonstrated only viable cells (0% cell death) regardless of the presence (well 5: 84 viable, 0 non–viable cells) or absence (well 6: 84 viable, 0 non–viable cells) of quantum dots. Similarly, irradiated cells without quantum dots demonstrated only viable cells regardless of exposure to 50 pulses (well 2: 77 viable, 0 non–viable cells) or 100 pulses (well 4: 73 viable, 0 non–viable cells). In dramatic contrast, endothelial cells labeled with quantum dots and exposed to 50 laser pulses demonstrated 100% non–viable cells (well 1: 0 viable, 63 non–viable cells). Endothelial cells labeled with quantum dots and exposed to 100 laser pulses demonstrated complete disintegration with few identifiable cells remaining (well 3: 0 viable, 1 non–viable cell).

Conclusions: : Antibody conjugated quantum dot mediated surface plasmon resonance can achieve 100% vascular endothelial cell lethality in vitro. Application of this technology in vivo holds promise for treatment of angiogenesis as in proliferative diabetic retinopathy and choroidal neovascularization.

Keywords: neovascularization • growth factors/growth factor receptors • phagocytosis and killing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×